AMD
Advanced Micro Devices IncTrades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-15 | Papermaster Mark D |
Chief Technology Officer & EVP |
Convert↓
Filing footnotes — Stock Option Grant (Direct)
The options vest 1/3 on each of August 9, 2021, 2022 and 2023. |
Stock Option Grant
|
6,000 |
| 2026-06-15 | GUIDO PHILIP |
EVP & Chief Commercial Officer |
Convert↑
|
Common Stock
|
7,495 |
| 2026-06-15 | Papermaster Mark D |
Chief Technology Officer & EVP |
Convert↑
Filing footnotes — Common Stock (Direct)
The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025. |
Common Stock
|
6,000 |
| 2026-06-15 | Papermaster Mark D |
Chief Technology Officer & EVP |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025. |
Common Stock
|
6,000 |
| 2026-06-15 | GUIDO PHILIP |
EVP & Chief Commercial Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each RSU represents a contingent right to receive one share of AMD's common stock. The RSUs vest 1/3 on each of June 15, 2024, 2025 and 2026. |
Restricted Stock Units
|
7,495 |
| 2026-06-15 | GUIDO PHILIP |
EVP & Chief Commercial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The shares are withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the release of restricted stock units ("RSU"). |
Common Stock
|
2,950 |
| 2026-06-12 | Su Lisa T |
Director, Chair, President & CEO |
Gift↓
|
Common Stock
|
30,000 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $476.14 to $476.71 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
500 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $455.98 to $456.93 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
6,638 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $464.82 to $465.81 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
1,100 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $453.96 to $454.95 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
9,392 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $473.12 to $474.11 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
3,700 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $470.10 to $471.09 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
7,426 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $451.96 to $452.93 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
12,862 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $474.12 to $475.05 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
3,855 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $475.13 to $475.84 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
1,300 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $449.94 to $450.91 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
700 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $468.07 to $469.06 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
5,002 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $456.98 to $457.97 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
7,351 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $458.02 to $459.01 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
5,700 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $467.00 to $467.96 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
3,679 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $452.96 to $453.95 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
14,458 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $462.50 to $463.23 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
1,900 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $469.10 to $470.09 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
6,814 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $472.12 to $473.11 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
3,509 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $461.37 to $462.32 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
900 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $460.13 to $461.09 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
1,700 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $450.96 to $451.95 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
4,400 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $448.85 to $449.83 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
2,720 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $459.02 to $459.99 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
2,891 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $465.84 to $466.69 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
3,337 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $471.10 to $472.09 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
5,376 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $454.96 to $455.92 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
7,390 |
| 2026-06-10 | Su Lisa T |
Director, Chair, President & CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025. Transaction executed in multiple trades at prices ranging from $463.66 to $464.39 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
400 |
| 2026-06-02 | Denzel Nora |
Director |
Sell↓
|
Common Stock
|
8,626 |
| 2026-05-29 | Denzel Nora |
Director |
Sell↓
|
Common Stock
|
1,821 |
| 2026-05-20 | Norrod Forrest Eugene |
EVP & GM DESG |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. Transaction executed in multiple trades at prices ranging from $430.17 to $431.15 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
5,032 |
| 2026-05-20 | Norrod Forrest Eugene |
EVP & GM DESG |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. Transaction executed in multiple trades at prices ranging from $431.18 to $432.00 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
3,287 |
| 2026-05-20 | Norrod Forrest Eugene |
EVP & GM DESG |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. Transaction executed in multiple trades at prices ranging from $427.03 to $427.98 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
516 |
| 2026-05-20 | Norrod Forrest Eugene |
EVP & GM DESG |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. Transaction executed in multiple trades at prices ranging from $429.05 to $430.02 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
2,667 |
| 2026-05-20 | Norrod Forrest Eugene |
EVP & GM DESG |
Convert↑
Filing footnotes — Common Stock (Direct)
The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025. |
Common Stock
|
8,237 |
| 2026-05-20 | Norrod Forrest Eugene |
EVP & GM DESG |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. Transaction executed in multiple trades at prices ranging from $435.53 to $436.50 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
890 |
| 2026-05-20 | Norrod Forrest Eugene |
EVP & GM DESG |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. Transaction executed in multiple trades at prices ranging from $434.53 to $435.44 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
1,562 |
| 2026-05-20 | Norrod Forrest Eugene |
EVP & GM DESG |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. Transaction executed in multiple trades at prices ranging from $428.04 to $428.94 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
1,975 |
| 2026-05-20 | Norrod Forrest Eugene |
EVP & GM DESG |
Convert↓
Filing footnotes — Stock Option Grant (Direct)
The options vest 1/3 on each of August 9, 2020, 2021 and 2022. |
Stock Option Grant
|
8,237 |
| 2026-05-20 | Norrod Forrest Eugene |
EVP & GM DESG |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. Transaction executed in multiple trades at prices ranging from $433.32 to $434.20 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
1,284 |
| 2026-05-20 | Norrod Forrest Eugene |
EVP & GM DESG |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025. Transaction executed in multiple trades at prices ranging from $432.28 to $433.25 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
Common Stock
|
2,274 |
| 2026-05-15 | Papermaster Mark D |
Chief Technology Officer & EVP |
Convert↓
Filing footnotes — Stock Option Grant (Direct)
The options vest 1/3 on each of August 9, 2021, 2022 and 2023. |
Stock Option Grant
|
6,000 |
| 2026-05-15 | Papermaster Mark D |
Chief Technology Officer & EVP |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025. |
Common Stock
|
6,000 |
| 2026-05-15 | Papermaster Mark D |
Chief Technology Officer & EVP |
Convert↑
Filing footnotes — Common Stock (Direct)
The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025. |
Common Stock
|
6,000 |